OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multitarget Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: An Opportunity or an illusion?
María João Matos
Future Medicinal Chemistry (2021) Vol. 13, Iss. 15, pp. 1301-1309
Closed Access | Times Cited: 11
María João Matos
Future Medicinal Chemistry (2021) Vol. 13, Iss. 15, pp. 1301-1309
Closed Access | Times Cited: 11
Showing 11 citing articles:
Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis
Anna Sampietro, F. Javier Pérez-Areales, Paula Felippe Martinez, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 545-545
Open Access | Times Cited: 32
Anna Sampietro, F. Javier Pérez-Areales, Paula Felippe Martinez, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 545-545
Open Access | Times Cited: 32
Evaluation of pyrimidine/pyrrolidine-sertraline based hybrids as multitarget anti-Alzheimer agents: In-vitro, in-vivo, and computational studies
Muhammad Aamir Javed, Muhammad Saeed Jan, Abdullah M. Shbeer, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114239-114239
Open Access | Times Cited: 18
Muhammad Aamir Javed, Muhammad Saeed Jan, Abdullah M. Shbeer, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114239-114239
Open Access | Times Cited: 18
ROS-responsive hierarchical targeting vehicle-free nanodrugs for three-pronged Parkinson’s disease therapy
Zhongxiong Fan, Hao Jin, Xiaofeng Tan, et al.
Chemical Engineering Journal (2023) Vol. 466, pp. 143245-143245
Closed Access | Times Cited: 6
Zhongxiong Fan, Hao Jin, Xiaofeng Tan, et al.
Chemical Engineering Journal (2023) Vol. 466, pp. 143245-143245
Closed Access | Times Cited: 6
Elaboration of the Effective Multi-Target Therapeutic Platform for the Treatment of Alzheimer’s Disease Based on Novel Monoterpene-Derived Hydroxamic Acids
Yulia Aleksandrova, Aldar A. Munkuev, Evgenii S. Mozhaitsev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9743-9743
Open Access | Times Cited: 5
Yulia Aleksandrova, Aldar A. Munkuev, Evgenii S. Mozhaitsev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9743-9743
Open Access | Times Cited: 5
Rational design, synthesis, biological evaluation, and molecular modeling of novel naphthamide derivatives possessing potent, reversible, and competitive inhibitory mode of action over human monoamine oxidase
Ahmed Elkamhawy, Jong‐Min Oh, Minkyoung Kim, et al.
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 179-193
Closed Access | Times Cited: 1
Ahmed Elkamhawy, Jong‐Min Oh, Minkyoung Kim, et al.
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 179-193
Closed Access | Times Cited: 1
Synthesis and biological evaluation of O4′-benzyl-hispidol derivatives and analogs as dual monoamine oxidase-B inhibitors and anti-neuroinflammatory agents
Ahmed H.E. Hassan, Yeonwoo Choi, Rium Kim, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117826-117826
Closed Access | Times Cited: 1
Ahmed H.E. Hassan, Yeonwoo Choi, Rium Kim, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117826-117826
Closed Access | Times Cited: 1
Recent advances in potential enzymes and their therapeutic inhibitors for the treatment of Alzheimer's disease
Zahra Farajzadeh Vahid, Morteza Eskandani, Hamed Dadashi, et al.
Heliyon (2024) Vol. 10, Iss. 23, pp. e40756-e40756
Open Access | Times Cited: 1
Zahra Farajzadeh Vahid, Morteza Eskandani, Hamed Dadashi, et al.
Heliyon (2024) Vol. 10, Iss. 23, pp. e40756-e40756
Open Access | Times Cited: 1
Interplay Between Endocannabinoid System and Neurodegeneration: Focus on Polypharmacology
Francesca Seghetti, Silvia Gobbi, Federica Belluti, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 28, pp. 4796-4830
Open Access | Times Cited: 5
Francesca Seghetti, Silvia Gobbi, Federica Belluti, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 28, pp. 4796-4830
Open Access | Times Cited: 5
Network-Pharmacology and Central Nervous System Drug Development
Alan Talevi
AAPS introductions in the pharmaceutical sciences (2024), pp. 213-227
Closed Access
Alan Talevi
AAPS introductions in the pharmaceutical sciences (2024), pp. 213-227
Closed Access
Comparison of Docking Scoring Functions by InterCriteria Analysis on a Set of Protein Targets Related to Alzheimer and Parkinson Diseases
Petko Alov, Ilza Pajeva, Ivanka Tsakovska, et al.
Lecture notes in networks and systems (2023), pp. 98-110
Closed Access
Petko Alov, Ilza Pajeva, Ivanka Tsakovska, et al.
Lecture notes in networks and systems (2023), pp. 98-110
Closed Access
Treating Neurodegenerative Diseases with Multitarget Drugs: An Interview With Maria João Matos
María João Matos
Future Medicinal Chemistry (2022) Vol. 14, Iss. 12, pp. 847-850
Closed Access
María João Matos
Future Medicinal Chemistry (2022) Vol. 14, Iss. 12, pp. 847-850
Closed Access
